Remedium Capital Partners, Llc Portfolio Stock Holdings

Remedium Capital Partners, Llc disclosed 6 stock positions valued at approximately $319.8 million in its latest SEC 13F filing. The largest holdings include Spyre Therapeutics Inc and Apogee Therapeutics Inc. The filing reflects positions held as of March 31, 2026 and was filed on May 13, 2026.

Report Period
March 31, 2026
No. of Stocks
6
Portfolio Value
$319.8M
Holdings by Sector
Remedium Capital Partners, Llc Portfolio Holdings in Q1 2026

2 holdings in the latest reporting period.

Page 1 of 1
CompanySymbolSectorPortfolio %SharesChange (Shares)Change %Value
Spyre Therapeutics IncSYREHealthcare30.09%1,907,327+451,096+30.98%$96,205,574
Apogee Therapeutics IncAPGEHealthcare15.36%583,591--$49,120,854